Experiences with an anti-rheumatis drug Soripal
Gross, D.
Schweizerische Rundschau für Medizin Praxis 60(40): 1334-1336
1971
ISSN/ISBN: 1013-2058 PMID: 5315454 Document Number: 36306
Document emailed within 1 workday
Related Documents
Mangesho, P.E.; Reynolds, J.; Lemnge, M.; Vestergaard, L.S.; Chandler, C.I.R. 2014: "Every drug goes to treat its own disease…" - a qualitative study of perceptions and experiences of taking anti-retrovirals concomitantly with anti-malarials among those affected by HIV and malaria in Tanzania Malaria Journal 13: 491Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Beggs, W.H. 1993: Anti-Candida activity of the anti-cancer drug tamoxifen Research Communications in Chemical Pathology and Pharmacology 80(1): 125-128
Kumar, S.; Rao, P.S.S.; Earla, R.; Kumar, A. 2015: Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems Expert Opinion on Drug Metabolism and Toxicology 11(3): 343-355
Bunton, R.W. 1983: Reintroduction of anti-inflammatory drug therapy after drug-associated gastrointestinal disturbances New Zealand Medical Journal 96(726): 144
Hegazy, S.K.; El-Azab, G.A.; Zakaria, F.; Mostafa, M.F.; El-Ghoneimy, R.A. 2022: Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer Life Sciences 299: 120536
Dworacka, M.; Nowocień, T. 2017: Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(248): 61-64
Yamada, Y.; Nakahara, M.; Kohno, M.; Otsuka, M.; Takaiti, O. 1989: Metabolic fate of the new anti-ulcer drug enprostil in animals. 4th communication: effect on hepatic drug metabolizing enzyme system in rats Arzneimittel-Forschung 39(3): 356-360
Zhang, J.; Li, H.-F.; Fan, W.; Liu, Z.; Man, S.-L.; Si, S.-Y.; Gao, W.-Y. 2014: Regularity of drugs compatibility of anti-hepatoma traditional Chinese medicine ancient prescriptions and risk evaluation of anti-hepatoma new drug research and development Zhongguo Zhong Yao Za Zhi 39(19): 3870-3875
Weiss-Simon, C.; Spangenberg, G.; Michel, D. 1980: Anti-arrhythmic agents. 2. Special anti-arrhythmic effect, known drug interactions Fortschritte der Medizin 98(15): 569-572
Ferrari, M.; Bigi, N. 1970: Clinical experiences with a new anti-arrhythmic agent: disopyramide (Rhythmodan) Minerva Medica 61(71): 3728-3733
Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F. 2013: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network Antiviral Therapy 18(6): 831-836
Kristensen, Jørgen.Schøler.; Bukh, A. 2009: Hematology: experiences with common national reports on new anti-cancer drugs Ugeskrift for Laeger 171(13): 1089
Retterstol, N. 1971: Drug abuse--Danish experiences Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(28): 2036-2037
Müller, D. 1970: Report on experiences with the drug Haemiton Das Deutsche Gesundheitswesen 25(32): 1517
Herger, R. 1972: Experiences with the new vasotherapeutic drug Trental in dermatology Fortschritte der Medizin 90(24): 865-872
Jones, P.Sean. 2005: On a never-ending waiting list: toward equitable access to anti-retroviral treatment? Experiences from Zambia Health and Human Rights 8(2): 76-102
Haładyj, M.; Suwalski, K.; Mojkowski, W.; Peczalski, K.; Stopczyk, M. 1983: Anti-arrhythmia stimulators in the treatment of paroxysmal tachycardia--principles of action and first clinical experiences Kardiologia Polska 26(7): 601-609
Porst, H.; van Ahlen, H. 1989: Drug-induced priapism--a report of experiences in 101 cases Der Urologe. Ausg. a 28(2): 84-87